Sort   by:  
 Page size 
TranscriptomicsSaccharomyces cerevisiae cells: W303-1A vs W303-1A delta MSN2, MSN4
Transcriptional profiling of Saccharomyces cerevisiae cells comparing the W303-1A wildtype with the W303-1A double mutant for MSN2 and MSN4 during zinc deficient conditions Keywords: Genetic modification with zinc limitation Two condition experiment, W303-1A vs W303-1A delta MSN2, MSN4. Biological ...
ORGANISM(S): Saccharomyces cerevisiae 
2008-12-22 | E-GEOD-11878 | biostudies-arrayexpress
UnknownEfficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naive and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.
Not available
S-EPMC10806710 | biostudies-literature
UnknownAcalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.
Not available
S-EPMC8547923 | biostudies-literature
UnknownDisease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.
Not available
S-EPMC8166804 | biostudies-literature
UnknownEffect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial.
Not available
S-EPMC6583488 | biostudies-literature
UnknownDisease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
Not available
S-EPMC8252761 | biostudies-literature
UnknownTocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial.
Not available
S-EPMC12322455 | biostudies-literature
UnknownGender Differences in Fears Related to Low-Risk Papillary Thyroid Cancer and Its Treatment.
Not available
S-EPMC10326729 | biostudies-literature
UnknownPrediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595 | biostudies-literature
UnknownHeterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
Not available
S-EPMC10031504 | biostudies-literature
Sort   by:  
 Page size